Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Infection-Control Programs Suffering, Hospitals Report
Infections acquired at hospitals lead to almost 10,000 deaths each year, costing the United States health care system more than $20 billion, the Wall Street Journal reported Tuesday.
Despite justification for beefing up U.S. hospitals' infection-control efforts, a new survey found that almost 41 percent of nearly 2,000 participants said their hospital infection-control budgets were being cut, the newspaper reported. Funding cuts were affecting technology, staff, education, products and equipment, the survey by the Association for Professionals in Infection Control (APIC) revealed.
Moreover, 40 percent of respondents said they were affected by layoffs or a reduction in hours, and one-third said their departments had job freezes, the Journal reported.
The survey also found that only about 20 percent of respondents said their institutions had electronic reporting systems -- referred to as "data mining" -- that helped identify infection clusters in real time, the newspaper said.
One infection-control director from Tacoma, Wash., reported that a data-mining effort identified a pattern of urinary tract infections that ended up preventing an estimated 187 additional infections over 16 months and saving her institution about $1.5 million, the Journal said.
HIV Cases Said Leveling Off in South Africa
HIV cases in South Africa have leveled off to about 10.9 percent of residents aged two and older, the BBC reports of a new study.
The rate may actually be falling among children and teenagers partly because of increased condom use, the network reported of survey findings by the Human Sciences Research Council.
But the report termed the overall situation "dire," since South Africa has the world's largest HIV-positive population, at 5.5 million.
Women between 20 and 34 years old continued to be the worst affected, with 33 percent carrying HIV, according to the report.
FDA: Don't Use Clarcon Skin Products
Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling skin sanitizers and skin protectants sold under several brand names because the products may be contaminated with bacteria that could make users sick, the U.S. Food and Drug Administration said.
The agency issued a news release warning consumers to refrain from using all products made by the company. It said an analysis of several samples revealed disease-causing bacteria, some of which are associated with unsanitary conditions. The germs could cause dangerous infections of the skin and underlying tissue, the FDA added.
The products -- promoted in some cases as antimicrobial agents that can prevent infection in open wounds -- should not be used and be disposed of in the household trash, the agency said. A partial list of affected products includes: